HIMS & HERS HEALTH INC (HIMS)
US4330001060 - Common Stock
HIMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. While HIMS has a great health rating, its profitability is only average at the moment. HIMS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
HIMS had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 16.81%, HIMS belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
HIMS has a Return On Equity of 23.01%. This is amongst the best in the industry. HIMS outperforms 92.59% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.89%, HIMS is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.81% | ||
| ROE | 23.01% | ||
| ROIC | 7.89% |
ROA(3y)-16.29%
ROA(5y)-9.96%
ROE(3y)-20.03%
ROE(5y)-12.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of HIMS (8.15%) is better than 88.89% of its industry peers.
The Operating Margin of HIMS (3.62%) is comparable to the rest of the industry.
HIMS has a better Gross Margin (81.13%) than 93.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.62% | ||
| PM (TTM) | 8.15% | ||
| GM | 81.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIMS has an Altman-Z score of 23.20. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
HIMS has a better Altman-Z score (23.20) than 99.07% of its industry peers.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 23.2 |
ROIC/WACC0.86
WACC9.21%
2.3 Liquidity
A Current Ratio of 2.14 indicates that HIMS has no problem at all paying its short term obligations.
The Current ratio of HIMS (2.14) is better than 75.00% of its industry peers.
HIMS has a Quick Ratio of 1.82. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS's Quick ratio of 1.82 is fine compared to the rest of the industry. HIMS outperforms 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 358.82% over the past year.
The Revenue has grown by 56.70% in the past year. This is a very strong growth!
EPS 1Y (TTM)358.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
Revenue 1Y (TTM)56.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.13%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.47% yearly.
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 33.86% on average per year.
EPS Next Y608.15%
EPS Next 2Y164.61%
EPS Next 3Y104.85%
EPS Next 5Y72.47%
Revenue Next Year67.99%
Revenue Next 2Y52.23%
Revenue Next 3Y39.44%
Revenue Next 5Y33.86%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 59.55, the valuation of HIMS can be described as expensive.
HIMS's Price/Earnings ratio is in line with the industry average.
HIMS is valuated expensively when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 47.62, the valuation of HIMS can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, HIMS is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 59.55 | ||
| Fwd PE | 47.62 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS indicates a slightly more expensive valuation: HIMS is more expensive than 60.19% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS indicates a somewhat cheap valuation: HIMS is cheaper than 62.04% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.26 | ||
| EV/EBITDA | 91.86 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 104.85% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y164.61%
EPS Next 3Y104.85%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HIMS & HERS HEALTH INC
NYSE:HIMS (12/20/2024, 8:16:42 PM)
After market: 26.38 +0.18 (+0.69%)26.2
-0.16 (-0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners65.92%
Inst Owner Change0.02%
Ins Owners11.56%
Ins Owner Change-3.76%
Market Cap5.72B
Analysts72
Price Target25.34 (-3.28%)
Short Float %23.11%
Short Ratio2.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)352.27%
Min EPS beat(2)37.66%
Max EPS beat(2)666.87%
EPS beat(4)4
Avg EPS beat(4)291.33%
Min EPS beat(4)37.66%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)155.53%
EPS beat(12)9
Avg EPS beat(12)95.7%
EPS beat(16)11
Avg EPS beat(16)66.46%
Revenue beat(2)2
Avg Revenue beat(2)3.09%
Min Revenue beat(2)3%
Max Revenue beat(2)3.17%
Revenue beat(4)3
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)1.45%
Revenue beat(12)10
Avg Revenue beat(12)3.73%
Revenue beat(16)13
Avg Revenue beat(16)-2.61%
PT rev (1m)14.51%
PT rev (3m)11.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)239.41%
EPS NY rev (1m)8.64%
EPS NY rev (3m)138.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)41.04%
Revenue NY rev (1m)0.88%
Revenue NY rev (3m)5.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 59.55 | ||
| Fwd PE | 47.62 | ||
| P/S | 4.61 | ||
| P/FCF | 38.26 | ||
| P/OCF | 30.66 | ||
| P/B | 13.01 | ||
| P/tB | 20.26 | ||
| EV/EBITDA | 91.86 |
EPS(TTM)0.44
EY1.68%
EPS(NY)0.55
Fwd EY2.1%
FCF(TTM)0.68
FCFY2.61%
OCF(TTM)0.85
OCFY3.26%
SpS5.68
BVpS2.01
TBVpS1.29
PEG (NY)0.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.81% | ||
| ROE | 23.01% | ||
| ROCE | 9.99% | ||
| ROIC | 7.89% | ||
| ROICexc | 18.14% | ||
| ROICexgc | 93.35% | ||
| OM | 3.62% | ||
| PM (TTM) | 8.15% | ||
| GM | 81.13% | ||
| FCFM | 12.05% |
ROA(3y)-16.29%
ROA(5y)-9.96%
ROE(3y)-20.03%
ROE(5y)-12.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover2.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 270.83% | ||
| Cap/Sales | 2.98% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 318.65% | ||
| Profit Quality | 147.76% | ||
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 23.2 |
F-Score7
WACC9.21%
ROIC/WACC0.86
Cap/Depr(3y)166.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)358.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
EPS Next Y608.15%
EPS Next 2Y164.61%
EPS Next 3Y104.85%
EPS Next 5Y72.47%
Revenue 1Y (TTM)56.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.13%
Revenue Next Year67.99%
Revenue Next 2Y52.23%
Revenue Next 3Y39.44%
Revenue Next 5Y33.86%
EBIT growth 1Y222.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year624.74%
EBIT Next 3Y126.74%
EBIT Next 5Y69.35%
FCF growth 1Y615.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y914.6%
OCF growth 3YN/A
OCF growth 5YN/A